Drug treatment of Parkinson's disease: is "polypharmacy" best?
Swanson
P D
PD
Division of Neurology, University of Washington School of Medicine, Seattle 98195.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents